Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 30 | 2020 | 4784 | 0.920 |
Why?
|
Endometrial Neoplasms | 14 | 2020 | 1388 | 0.890 |
Why?
|
Metformin | 6 | 2018 | 393 | 0.570 |
Why?
|
Obesity | 6 | 2024 | 2904 | 0.470 |
Why?
|
Protein-Tyrosine Kinases | 11 | 2006 | 1838 | 0.350 |
Why?
|
Cystadenocarcinoma, Serous | 4 | 2013 | 496 | 0.350 |
Why?
|
Endometrium | 4 | 2018 | 460 | 0.310 |
Why?
|
Hypoglycemic Agents | 3 | 2016 | 598 | 0.280 |
Why?
|
Receptor, EphA2 | 4 | 2009 | 138 | 0.260 |
Why?
|
Omentum | 2 | 2020 | 107 | 0.260 |
Why?
|
Carcinoma, Endometrioid | 3 | 2016 | 327 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-abl | 2 | 2004 | 84 | 0.230 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2003 | 153 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2020 | 9036 | 0.220 |
Why?
|
Kallikreins | 1 | 2003 | 86 | 0.210 |
Why?
|
Ovary | 3 | 2020 | 688 | 0.210 |
Why?
|
Lectins | 2 | 2020 | 148 | 0.210 |
Why?
|
Interleukin-2 | 5 | 1994 | 889 | 0.210 |
Why?
|
Receptors, Interleukin-2 | 6 | 1994 | 195 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2004 | 484 | 0.200 |
Why?
|
Neovascularization, Pathologic | 7 | 2011 | 1585 | 0.190 |
Why?
|
PTEN Phosphohydrolase | 3 | 2016 | 1012 | 0.190 |
Why?
|
Everolimus | 2 | 2021 | 436 | 0.190 |
Why?
|
Proto-Oncogene Proteins | 5 | 2014 | 2616 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 1415 | 0.180 |
Why?
|
Cell Line, Tumor | 20 | 2020 | 14825 | 0.180 |
Why?
|
Stromal Cells | 2 | 2016 | 826 | 0.180 |
Why?
|
Estradiol | 3 | 2017 | 828 | 0.170 |
Why?
|
RNA, Small Interfering | 6 | 2013 | 2196 | 0.170 |
Why?
|
Biomarkers, Tumor | 7 | 2016 | 10699 | 0.170 |
Why?
|
Cyclopentanes | 1 | 2020 | 43 | 0.170 |
Why?
|
ras Proteins | 2 | 2014 | 804 | 0.170 |
Why?
|
RNA Interference | 3 | 2009 | 1386 | 0.170 |
Why?
|
src Homology Domains | 2 | 1999 | 133 | 0.160 |
Why?
|
Immunohistochemistry | 13 | 2017 | 7663 | 0.160 |
Why?
|
Adenosine Triphosphatases | 2 | 2013 | 427 | 0.160 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 1999 | 97 | 0.160 |
Why?
|
Female | 49 | 2024 | 148723 | 0.160 |
Why?
|
Endometrial Hyperplasia | 2 | 2016 | 124 | 0.150 |
Why?
|
Cell Proliferation | 14 | 2020 | 7234 | 0.150 |
Why?
|
Healthy Lifestyle | 1 | 2018 | 42 | 0.150 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 283 | 0.150 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 661 | 0.140 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2017 | 46 | 0.140 |
Why?
|
Weight Reduction Programs | 1 | 2018 | 74 | 0.140 |
Why?
|
Protein Kinases | 4 | 1994 | 902 | 0.140 |
Why?
|
Carcinoma | 3 | 2013 | 2609 | 0.140 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2017 | 161 | 0.140 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2016 | 42 | 0.130 |
Why?
|
Cloning, Molecular | 6 | 2006 | 1431 | 0.130 |
Why?
|
Proteome | 1 | 2020 | 571 | 0.130 |
Why?
|
RNA, Messenger | 7 | 2014 | 6397 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2014 | 1280 | 0.130 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2006 | 163 | 0.120 |
Why?
|
Lymphocyte Activation | 4 | 1999 | 1723 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2020 | 3911 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2017 | 1401 | 0.120 |
Why?
|
Influenza, Human | 1 | 2022 | 759 | 0.120 |
Why?
|
Neoplasm Proteins | 1 | 2006 | 3344 | 0.120 |
Why?
|
Pyrimidines | 3 | 2020 | 3662 | 0.120 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 692 | 0.120 |
Why?
|
Inflammation | 1 | 2024 | 2516 | 0.120 |
Why?
|
Alzheimer Disease | 1 | 2022 | 817 | 0.120 |
Why?
|
Gene Amplification | 2 | 2008 | 766 | 0.120 |
Why?
|
Animals | 26 | 2024 | 62012 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 9 | 2014 | 3603 | 0.110 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 135 | 0.110 |
Why?
|
Cytokines | 2 | 2020 | 2826 | 0.110 |
Why?
|
Mice | 19 | 2024 | 35574 | 0.110 |
Why?
|
Humans | 54 | 2024 | 270462 | 0.110 |
Why?
|
Peritoneal Neoplasms | 1 | 2020 | 855 | 0.110 |
Why?
|
Exosomes | 1 | 2016 | 255 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2013 | 28 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1826 | 0.110 |
Why?
|
Antineoplastic Agents | 9 | 2021 | 14614 | 0.110 |
Why?
|
Streptozocin | 1 | 2013 | 70 | 0.110 |
Why?
|
Cell Cycle | 3 | 2008 | 2137 | 0.110 |
Why?
|
Hyperinsulinism | 1 | 2013 | 86 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2016 | 5403 | 0.100 |
Why?
|
Apoptosis | 11 | 2016 | 7752 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1999 | 1469 | 0.100 |
Why?
|
Body Weight | 1 | 2016 | 1311 | 0.100 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 246 | 0.100 |
Why?
|
Adipose Tissue | 2 | 2016 | 717 | 0.100 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2013 | 317 | 0.100 |
Why?
|
Receptors, Progesterone | 4 | 2017 | 1603 | 0.090 |
Why?
|
Paclitaxel | 2 | 2016 | 2100 | 0.090 |
Why?
|
Down-Regulation | 5 | 2020 | 2091 | 0.090 |
Why?
|
T-Lymphocytes | 5 | 1999 | 3943 | 0.090 |
Why?
|
Proteins | 1 | 1999 | 2043 | 0.090 |
Why?
|
Carrier Proteins | 1 | 1999 | 2099 | 0.090 |
Why?
|
Cell Cycle Proteins | 3 | 1994 | 2115 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2010 | 77 | 0.090 |
Why?
|
Liposomes | 3 | 2006 | 705 | 0.090 |
Why?
|
Aptamers, Nucleotide | 1 | 2010 | 58 | 0.080 |
Why?
|
Sirolimus | 1 | 2014 | 831 | 0.080 |
Why?
|
Cisplatin | 3 | 2013 | 2496 | 0.080 |
Why?
|
Pericytes | 1 | 2010 | 91 | 0.080 |
Why?
|
Mutation | 6 | 2020 | 15901 | 0.080 |
Why?
|
Estrous Cycle | 1 | 2009 | 40 | 0.080 |
Why?
|
Mice, Nude | 7 | 2010 | 4329 | 0.080 |
Why?
|
Amino Acid Sequence | 7 | 2007 | 4569 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2014 | 3656 | 0.080 |
Why?
|
Genetic Therapy | 2 | 2006 | 1714 | 0.080 |
Why?
|
Tumor Cells, Cultured | 6 | 2010 | 5759 | 0.080 |
Why?
|
Cation Transport Proteins | 1 | 2009 | 170 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2008 | 121 | 0.070 |
Why?
|
GPI-Linked Proteins | 2 | 2020 | 232 | 0.070 |
Why?
|
Ribonuclease III | 1 | 2008 | 182 | 0.070 |
Why?
|
Signal Transduction | 8 | 2013 | 12098 | 0.070 |
Why?
|
Molecular Sequence Data | 7 | 2007 | 6686 | 0.070 |
Why?
|
Cell Division | 4 | 1999 | 2657 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 1564 | 0.070 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2010 | 460 | 0.070 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2008 | 517 | 0.070 |
Why?
|
Oligopeptides | 1 | 2009 | 447 | 0.070 |
Why?
|
DEAD-box RNA Helicases | 1 | 2008 | 256 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5251 | 0.070 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 4044 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2004 | 1871 | 0.070 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2008 | 324 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2004 | 1944 | 0.070 |
Why?
|
Cell Movement | 4 | 2020 | 2471 | 0.070 |
Why?
|
Thromboplastin | 1 | 2005 | 33 | 0.070 |
Why?
|
Immunoconjugates | 1 | 2009 | 314 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2021 | 1709 | 0.060 |
Why?
|
Receptor, Notch1 | 1 | 2007 | 217 | 0.060 |
Why?
|
Gene Silencing | 3 | 2013 | 827 | 0.060 |
Why?
|
In Situ Hybridization | 2 | 2006 | 1050 | 0.060 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2006 | 214 | 0.060 |
Why?
|
Estrogens | 1 | 2009 | 808 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2020 | 2453 | 0.060 |
Why?
|
Piperazines | 2 | 2004 | 2145 | 0.060 |
Why?
|
Gene Expression Profiling | 6 | 2013 | 5141 | 0.060 |
Why?
|
Immunoenzyme Techniques | 3 | 2014 | 1189 | 0.060 |
Why?
|
MicroRNAs | 2 | 2016 | 2886 | 0.060 |
Why?
|
Base Sequence | 5 | 2010 | 5437 | 0.060 |
Why?
|
Cadherins | 1 | 2007 | 657 | 0.060 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2004 | 112 | 0.060 |
Why?
|
Rats, Zucker | 2 | 2014 | 60 | 0.060 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2003 | 37 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2004 | 156 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2006 | 2308 | 0.060 |
Why?
|
Rats | 3 | 2021 | 6524 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2006 | 611 | 0.050 |
Why?
|
Physical Conditioning, Animal | 1 | 2024 | 115 | 0.050 |
Why?
|
Carcinoma, Papillary | 2 | 2006 | 566 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 2 | 2010 | 1266 | 0.050 |
Why?
|
Incidence | 2 | 2011 | 5814 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2004 | 2474 | 0.050 |
Why?
|
Phosphorylation | 5 | 2004 | 4945 | 0.050 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2003 | 82 | 0.050 |
Why?
|
Blotting, Western | 4 | 2009 | 3586 | 0.050 |
Why?
|
Receptors, Estrogen | 2 | 2007 | 2159 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2003 | 726 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2024 | 7382 | 0.050 |
Why?
|
Imatinib Mesylate | 2 | 2004 | 1690 | 0.050 |
Why?
|
Taxoids | 1 | 2005 | 1015 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2021 | 2073 | 0.050 |
Why?
|
Phosphatidylcholines | 3 | 2006 | 128 | 0.050 |
Why?
|
Antibodies, Monoclonal | 4 | 2010 | 4479 | 0.050 |
Why?
|
Benzamides | 2 | 2004 | 1878 | 0.050 |
Why?
|
Peptides | 1 | 2007 | 1504 | 0.050 |
Why?
|
Epithelium | 1 | 2003 | 781 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 7096 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2005 | 893 | 0.050 |
Why?
|
Ki-67 Antigen | 2 | 2016 | 676 | 0.050 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2020 | 51 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 522 | 0.040 |
Why?
|
NEDD8 Protein | 1 | 2020 | 23 | 0.040 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 274 | 0.040 |
Why?
|
Polymers | 1 | 2021 | 222 | 0.040 |
Why?
|
DNA, Complementary | 2 | 1999 | 938 | 0.040 |
Why?
|
Lactoferrin | 1 | 2020 | 87 | 0.040 |
Why?
|
Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 1999 | 15 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2007 | 1582 | 0.040 |
Why?
|
Neoplasm Staging | 7 | 2013 | 14003 | 0.040 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 1999 | 28 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 354 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2007 | 1654 | 0.040 |
Why?
|
Yeasts | 1 | 1999 | 76 | 0.040 |
Why?
|
Insulin | 2 | 2016 | 1486 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 377 | 0.040 |
Why?
|
Uterine Neoplasms | 1 | 2003 | 576 | 0.040 |
Why?
|
3T3 Cells | 1 | 1999 | 383 | 0.040 |
Why?
|
Prognosis | 7 | 2014 | 22466 | 0.040 |
Why?
|
Risk Factors | 2 | 2016 | 17857 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2006 | 1899 | 0.040 |
Why?
|
Cell Lineage | 2 | 2004 | 697 | 0.040 |
Why?
|
Propensity Score | 1 | 2022 | 768 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2006 | 1525 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2010 | 1579 | 0.040 |
Why?
|
Up-Regulation | 3 | 2007 | 2421 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2020 | 409 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 2 | 2009 | 438 | 0.040 |
Why?
|
Rabbits | 1 | 1999 | 1028 | 0.040 |
Why?
|
Transplantation, Heterologous | 2 | 2011 | 1054 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2010 | 1121 | 0.040 |
Why?
|
Cell Survival | 3 | 2009 | 3059 | 0.040 |
Why?
|
Juvenile Hormones | 1 | 1996 | 7 | 0.030 |
Why?
|
Enzyme Induction | 2 | 1994 | 259 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2020 | 3027 | 0.030 |
Why?
|
Trans-Activators | 1 | 2003 | 1622 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2009 | 589 | 0.030 |
Why?
|
Middle Aged | 9 | 2022 | 90192 | 0.030 |
Why?
|
Protein Binding | 3 | 2009 | 3485 | 0.030 |
Why?
|
Uterus | 1 | 2021 | 798 | 0.030 |
Why?
|
Chronic Disease | 1 | 2022 | 1825 | 0.030 |
Why?
|
Polymerase Chain Reaction | 3 | 2014 | 3478 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2007 | 2929 | 0.030 |
Why?
|
Adiposity | 1 | 2018 | 238 | 0.030 |
Why?
|
Adiponectin | 1 | 2016 | 143 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 2319 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 274 | 0.030 |
Why?
|
Vaccination | 1 | 2022 | 1158 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1992 | 1135 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 474 | 0.030 |
Why?
|
Tumor Burden | 2 | 2013 | 2033 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 318 | 0.030 |
Why?
|
Body Composition | 1 | 2018 | 607 | 0.030 |
Why?
|
Leptin | 1 | 2016 | 306 | 0.030 |
Why?
|
Pyridones | 1 | 2017 | 360 | 0.030 |
Why?
|
Biomarkers | 2 | 2018 | 5059 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 16640 | 0.030 |
Why?
|
Adipocytes | 1 | 2016 | 298 | 0.030 |
Why?
|
Weight Loss | 1 | 2018 | 629 | 0.030 |
Why?
|
Phosphoproteins | 2 | 2016 | 1137 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 402 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2016 | 632 | 0.030 |
Why?
|
R-SNARE Proteins | 1 | 2013 | 19 | 0.030 |
Why?
|
Qa-SNARE Proteins | 1 | 2013 | 41 | 0.030 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2020 | 1094 | 0.030 |
Why?
|
Aged | 7 | 2022 | 73248 | 0.030 |
Why?
|
CD3 Complex | 1 | 1994 | 320 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 885 | 0.030 |
Why?
|
Exons | 2 | 2006 | 1381 | 0.030 |
Why?
|
Proto-Oncogenes | 1 | 2013 | 208 | 0.030 |
Why?
|
Cohort Studies | 2 | 2022 | 9470 | 0.030 |
Why?
|
Consensus Sequence | 1 | 1992 | 118 | 0.030 |
Why?
|
Golgi Apparatus | 1 | 2013 | 151 | 0.030 |
Why?
|
Cell Membrane | 2 | 2013 | 878 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 13396 | 0.030 |
Why?
|
Adult | 7 | 2022 | 81851 | 0.030 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 1992 | 103 | 0.030 |
Why?
|
DNA Methylation | 2 | 2014 | 2762 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 1996 | 867 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2020 | 4223 | 0.020 |
Why?
|
Enzyme Activation | 2 | 1992 | 1811 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2013 | 407 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2011 | 65 | 0.020 |
Why?
|
Survival Rate | 2 | 2020 | 12509 | 0.020 |
Why?
|
Endocytosis | 1 | 1992 | 233 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 737 | 0.020 |
Why?
|
Drosophila | 1 | 1996 | 909 | 0.020 |
Why?
|
Cell Line | 3 | 2013 | 5339 | 0.020 |
Why?
|
Transfection | 2 | 2008 | 3118 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2006 | 417 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 469 | 0.020 |
Why?
|
Multigene Family | 1 | 1992 | 469 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2006 | 1082 | 0.020 |
Why?
|
Body Mass Index | 1 | 2018 | 2238 | 0.020 |
Why?
|
Oncogenes | 1 | 1993 | 700 | 0.020 |
Why?
|
Neoplasms | 3 | 2004 | 15900 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 1656 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 1993 | 1126 | 0.020 |
Why?
|
Polycomb Repressive Complex 2 | 1 | 2010 | 161 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 2001 | 632 | 0.020 |
Why?
|
Copper-transporting ATPases | 1 | 2009 | 44 | 0.020 |
Why?
|
Neoplasm Grading | 1 | 2014 | 1822 | 0.020 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2009 | 168 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2008 | 4326 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2018 | 33696 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3029 | 0.020 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2009 | 199 | 0.020 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2010 | 263 | 0.020 |
Why?
|
Lymphocytes | 1 | 1994 | 1275 | 0.020 |
Why?
|
DNA Adducts | 1 | 2009 | 214 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 1992 | 809 | 0.020 |
Why?
|
Microvessels | 1 | 2009 | 145 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 1496 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 768 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 1429 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 303 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2009 | 214 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 311 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2006 | 253 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2009 | 1028 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 2007 | 172 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2009 | 669 | 0.020 |
Why?
|
Immunotherapy | 1 | 2020 | 3551 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2007 | 350 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2014 | 3341 | 0.020 |
Why?
|
Ascites | 1 | 2007 | 213 | 0.020 |
Why?
|
Bevacizumab | 1 | 2010 | 958 | 0.020 |
Why?
|
Cellular Senescence | 1 | 2008 | 389 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 879 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 806 | 0.020 |
Why?
|
Cells, Cultured | 1 | 1994 | 5694 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2011 | 3044 | 0.020 |
Why?
|
Immunoblotting | 1 | 2006 | 895 | 0.020 |
Why?
|
Binding Sites | 1 | 2009 | 2255 | 0.020 |
Why?
|
Gene Expression | 1 | 2013 | 3641 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2004 | 109 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 2056 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 3707 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2005 | 4961 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2007 | 592 | 0.010 |
Why?
|
Paraffin Embedding | 1 | 2004 | 223 | 0.010 |
Why?
|
Protein Conformation | 1 | 2007 | 1255 | 0.010 |
Why?
|
Mesna | 1 | 2003 | 67 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2008 | 1193 | 0.010 |
Why?
|
Caspases | 1 | 2005 | 679 | 0.010 |
Why?
|
Male | 2 | 2024 | 128209 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2007 | 1129 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 2357 | 0.010 |
Why?
|
Ifosfamide | 1 | 2003 | 357 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 1109 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 749 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1111 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 724 | 0.010 |
Why?
|
GTP Phosphohydrolases | 1 | 2004 | 338 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 4960 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1992 | 4134 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2007 | 1038 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 4117 | 0.010 |
Why?
|
Protein Array Analysis | 1 | 2003 | 503 | 0.010 |
Why?
|
Individuality | 1 | 1999 | 57 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 3214 | 0.010 |
Why?
|
RNA | 1 | 2004 | 1064 | 0.010 |
Why?
|
Odds Ratio | 1 | 2004 | 2310 | 0.010 |
Why?
|
beta Catenin | 1 | 2003 | 682 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6253 | 0.010 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2010 | 3399 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 9039 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2003 | 1712 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2008 | 30976 | 0.010 |
Why?
|
Logistic Models | 1 | 2004 | 3447 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 1996 | 125 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 5171 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1996 | 498 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 5001 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 9290 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2004 | 6238 | 0.010 |
Why?
|
Receptor, ErbB-2 | 1 | 2003 | 2650 | 0.010 |
Why?
|
Genome, Human | 1 | 2001 | 1885 | 0.010 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1992 | 37 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1992 | 34 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1992 | 330 | 0.010 |
Why?
|
Molecular Weight | 1 | 1992 | 721 | 0.010 |
Why?
|
Risk Assessment | 1 | 2004 | 6761 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1992 | 581 | 0.010 |
Why?
|
Gene Library | 1 | 1992 | 353 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1994 | 695 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1996 | 1503 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 1996 | 906 | 0.010 |
Why?
|
Disease Progression | 1 | 2001 | 6851 | 0.010 |
Why?
|
United States | 1 | 2004 | 15817 | 0.000 |
Why?
|
Bacterial Proteins | 1 | 1992 | 1091 | 0.000 |
Why?
|
Escherichia coli | 1 | 1992 | 1303 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2008 | 12020 | 0.000 |
Why?
|
Models, Biological | 1 | 1993 | 3194 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2008 | 16182 | 0.000 |
Why?
|